“Women Innovators” Prize in the leading category of the European Prize for Women Innovators program was awarded to PDC Therapeutics Co-Founder Prof. Rana Sanyal for her successful work in the field of biotechnology. […]

PDC Therapeutics, a biotech company developing targeted Polymer-Drug Conjugate technologies, announced the acceptance of a poster presentation about RS-0139 at the European Society for Medical Oncology Targeted Anticancer Therapies (ESMO TAT) 2023 Congress on 6-8 March in Paris – France, being known as “The Home of Phase I in Oncology”. […]

PDC Therapeutics, a biotech company developing targeted Polymer-Drug Conjugate technologies that are committed to advancing therapies with no compromise, announced the acceptance of RS-0139’s poster presentation at the ESMO Congress 2022 to be held in person on 9-13 September 2022 in Paris, France. […]